Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: MarketLine (a Datamonitor Company)
$175.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sun Pharmaceutical Industries to acquire stake in Ranbaxy Laboratories from Daiichi Sankyo


Sunday, 6 Apr 2014 07:00pm EDT 

Daiichi Sankyo Co Ltd:Says Sun Pharmaceutical Industries Ltd will acquire stake in Ranbaxy Laboratories, which is a 63.4 pct-owned subsidiary of Daiichi Sankyo, through stock swap by December.The company will receive 0.8 share of Sun Pharma for each share of Ranbaxy, to hold about 9 pct stake in Sun Pharma.